Ausgabe 11/2006
100 years of Alzheimer’s disease
Inhalt (24 Artikel)
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
R. Schliebs, T. Arendt
Alois Alzheimer revisited: differences in origin of the disease carrying his name
K. Maurer, S. Hoyer
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain
P. Riederer, S. Hoyer
Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer’s disease
R. Nardone, A. Bratti, F. Tezzon
The significance of neuroinflammation in understanding Alzheimer’s disease
P. Eikelenboom, R. Veerhuis, W. Scheper, A. J. M. Rozemuller, W. A. van Gool, J. J. M. Hoozemans
TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer’s disease
M. M. Edwards, S. R. Robinson
Evidence for involvement of glial cell activity in the control of extracellular D-serine contents in the rat brain
S. Kanematsu, S. Ishii, A. Umino, T. Fujihira, A. Kashiwa, N. Yamamoto, A. Kurumaji, T. Nishikawa
Endogenous overproduction of β-amyloid induces tau hyperphosphorylation and decreases the solubility of tau in N2a cells
Y.-P. Wang, X.-C. Wang, Q. Tian, Y. Yang, Q. Zhang, J.-Y. Zhang, Y.-C. Zhang, Z.-F. Wang, Q. Wang, H. Li, J.-Z. Wang
Compartmental protein expression of Tau, GSK-3β and TrkA in cholinergic neurons of aged rats
G. Niewiadomska, M. Baksalerska-Pazera, I. Lenarcik, G. Riedel
Prion protein gene M129 allele is a risk factor for Alzheimer’s disease
M. Gacia, K. Safranow, M. Styczyńska, K. Jakubowska, B. Pepłońska, M. Chodakowska-Żebrowska, I. Przekop, A. Słowik, E. Golańska, K. Hułas-Bigoszewska, D. Chlubek, D. Religa, C. Żekanowski, M. Barcikowska
Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer’s disease
C. Frey, A. Bonert, T. Kratzsch, G. Rexroth, W. Rösch, F. Müller-Spahn, K. Maurer, W. E. Müller, A. Eckert
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease
H. Kessler, F.-G. Pajonk, P. Meisser, T. Schneider-Axmann, K.-H. Hoffmann, T. Supprian, W. Herrmann, R. Obeid, G. Multhaup, P. Falkai, T. A. Bayer
CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodies
M. Bibl, B. Mollenhauer, H. Esselmann, P. Lewczuk, C. Trenkwalder, P. Brechlin, E. Rüther, J. Kornhuber, M. Otto, J. Wiltfang
Auditory event-related potentials in subcortical vascular cognitive impairment and in Alzheimer’s disease
E. G. Muscoso, E. Costanzo, O. Daniele, D. Maugeri, E. Natale, G. Caravaglios
Brain perfusion effects of cholinesterase inhibitors in Parkinson’s disease with dementia
R. Ceravolo, D. Volterrani, D. Frosini, S. Bernardini, C. Rossi, C. Logi, G. Manca, L. Kiferle, G. Mariani, L. Murri, U. Bonuccelli
Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer’s disease following chronic donepezil treatment
T. Darreh-Shori, L. Meurling, T. Pettersson, K. Hugosson, E. Hellström-Lindahl, N. Andreasen, L. Minthon, A. Nordberg
Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus
S. Yoshida, M. Maeda, S. Kaku, H. Ikeya, K. Yamada, S. Nakaike
Homocysteine but not neopterin declines in demented patients on B vitamins
B. Frick, B. Gruber, K. Schroecksnadel, F. Leblhuber, D. Fuchs
Staurosporin induces neurite outgrowth through ROS generation in HN33 hippocampal cell lines
J. Y. Min, M. H. Park, M. K. Park, K. W. Park, N. W. Lee, T. Kim, H. J. Kim, D. H. Lee